These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8080736)

  • 1. Is an increase in CA 125 in breast cancer patients an indicator of pleural metastases?
    Jäger W; Kissing A; Cilaci S; Melsheimer R; Lang N
    Br J Cancer; 1994 Sep; 70(3):493-5. PubMed ID: 8080736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CA 125 as an indicator of pleural metastases in breast cancer patients.
    Krämer S; Raff U; Jäger W; Lang N
    Anticancer Res; 1996; 16(5B):3165-8. PubMed ID: 8920785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CA 125 is an indicator for pleural metastases in breast cancer.
    Krämer S; Jäger W; Lang N
    Anticancer Res; 1997; 17(4B):2967-70. PubMed ID: 9329577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor marker CA 15-3 in breast cancer patients.
    Fejzić H; Mujagić S; Azabagić S; Burina M
    Acta Med Acad; 2015; 44(1):39-46. PubMed ID: 26062696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum CA-15.3 and CEA patterns in postsurgical follow-up, and in monitoring clinical course of metastatic cancer in patients with breast carcinoma.
    al-Jarallah MA; Behbehani AE; el-Nass SA; Temim L; Ebraheem AK; Ali MA; Szymendera JJ
    Eur J Surg Oncol; 1993 Feb; 19(1):74-9. PubMed ID: 8436243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of bone and liver metastases in breast cancer comparing tumor markers and imaging techniques.
    Zanco P; Rota G; Sportiello V; Borsato N; Ferlin G
    Int J Biol Markers; 1989; 4(2):103-5. PubMed ID: 2768888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CA 15-3 in patients with locoregional and metastatic breast carcinoma.
    Geraghty JG; Coveney EC; Sherry F; O'Higgins NJ; Duffy MJ
    Cancer; 1992 Dec; 70(12):2831-4. PubMed ID: 1451063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential use of tumour marker CA 15-3 in the staging and prognosis of patients with breast cancer.
    Horobin JM; Browning MC; McFarlane NP; Smith G; Preece PE; Wood RA; Cuschieri A
    J R Coll Surg Edinb; 1991 Aug; 36(4):219-21. PubMed ID: 1941734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer subtypes predispose the site of distant metastases.
    Soni A; Ren Z; Hameed O; Chanda D; Morgan CJ; Siegal GP; Wei S
    Am J Clin Pathol; 2015 Apr; 143(4):471-8. PubMed ID: 25779997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum alpha2-globulins in breast carcinoma.
    Minton JP; Bianco MA
    Arch Surg; 1974 Aug; 109(2):238-40. PubMed ID: 4136177
    [No Abstract]   [Full Text] [Related]  

  • 11. [Relation between hormone dependence and metastasis in breast cancer--SHBG assay in the study of breast cancer metastases].
    Murayama Y
    Nihon Gan Chiryo Gakkai Shi; 1987 Feb; 22(1):7-9. PubMed ID: 3611893
    [No Abstract]   [Full Text] [Related]  

  • 12. Breast cancer and clinical utility of CA 15-3 and CEA.
    Jäger W; Krämer S; Palapelas V; Norbert L
    Scand J Clin Lab Invest Suppl; 1995; 221():87-92. PubMed ID: 7652494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pleuropulmonary metastases of female cancers].
    Lemarié E; Milleron B
    Rev Pneumol Clin; 1999 Oct; 55(5):271-9. PubMed ID: 10637893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca 15-3 in the follow-up of localised breast cancer: a prospective study.
    Kokko R; Holli K; Hakama M
    Eur J Cancer; 2002 Jun; 38(9):1189-93. PubMed ID: 12044504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CA 15.3 and early diagnosis of recurrence in breast cancer].
    Basuyau JP; Brunelle P; Charrot P; Chevallier B; Delapierre F; Graic Y; Julien JP; Veyret C
    Bull Cancer; 1993 Mar; 80(3):213-8. PubMed ID: 8173173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased level of circulating adhesion molecules in the sera of breast cancer patients with distant metastases.
    Matsuura N; Narita T; Mitsuoka C; Kimura N; Kannagi R; Imai T; Funahashi H; Takagi H
    Jpn J Clin Oncol; 1997 Jun; 27(3):135-9. PubMed ID: 9255266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
    Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
    Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Elevated serum levels of interleukin-6 in breast cancer patients with visceral metastases: preliminary report].
    Abe M; Ouchi N; Harada Y; Mori S; Rikiishi H; Kumagai K
    Nihon Geka Gakkai Zasshi; 1992 Jan; 93(1):107. PubMed ID: 1549091
    [No Abstract]   [Full Text] [Related]  

  • 19. Breast carcinoma: pattern of metastasis at autopsy.
    Lee YT
    J Surg Oncol; 1983 Jul; 23(3):175-80. PubMed ID: 6345937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of bone scanning and CA 15-3 serum concentration in the follow-up of breast cancer.
    Montravers F; Younsi N; Rousseau C; Philippe C; Seddiki M; Uzan S; Izrael V; Talbot JN
    Anticancer Res; 1997; 17(3B):1683-6. PubMed ID: 9179218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.